A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery

References

• Abra RM, Bankert RB, Chen F, et al. (2002). The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically stabilized immunoliposomes and active loading gradients. J Liposome Res 12:1–3
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. (2005). Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44:68–97
   PubMed Web of Science ®Google Scholar
• Andrews CD, Huh MS, Patton K, et al. (2012). Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity. Mol Pharm 9:1118–25
   PubMedGoogle Scholar
• Araujo JG, Mota Ld, Leite EA, et al. (2011). Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice. Exp Biol Med (Maywood) 236:808–15
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748–58
   PubMed Web of Science ®Google Scholar
• Bertrand N, Simard P, Leroux JC. (2010). Serum-stable, long-circulating, pH-sensitive PEGylated liposomes. Methods Mol Biol 605:545–58
   PubMedGoogle Scholar
• Chang JS, Choi MJ, Cheong HS, Kim K. (2001). Development of Th1-mediated CD8_ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes. Vaccine 19:3608–14
   PubMed Web of Science ®Google Scholar
• Chang JS, Choi MJ, Kim TY, et al. (1999). Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes. Vaccine 17:1540–8
   PubMed Web of Science ®Google Scholar
• Chen D, Liu W, Shen Y, et al. (2011). Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomed 6:2053–61
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang H, Thor D, et al. (2012). Novel pH-sensitive cationic lipids with linear ortho ester linkers for gene delivery. Eur J Med Chem 52:159–72
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun J, Lu Y, et al. (2013). Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors. Int J Nanomed 8:1573–93
   PubMed Web of Science ®Google Scholar
• Collins D. (1995). pH-sensitive liposomes as tools for cytoplasmic delivery. In: Philippot JR, Schuber F, eds. Liposomes as tools in basic research and industry. Boca Raton: CRS Press, 201–14
   Google Scholar
• Conner J, Huang L. (1986). pH-sensitive Immunoliposomes as an efficient and target-specific carrier for antitumor drugs. Cancer Res 46:3431–5
   PubMed Web of Science ®Google Scholar
• Connor J, Yatvin MB, Huang, L. (1984). pH-sensitive liposomes: acid-induced liposome fusion. Proc Natl Acad Sci USA 81:1715–18
   PubMed Web of Science ®Google Scholar
• de Barros ALB, Mota LDG, Soares DCF, et al. (2011). Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification. Bioorg Med Chem Lett 21:7373–5
   PubMed Web of Science ®Google Scholar
• Di Marzio L, Marianecci C, Cinque B, et al. (2008). pH-sensitive non-phospholipid vesicle and macrophage-like cells: binding, uptake and endocytotic pathway. Biochim Biophys Acta 1778:2749–56
   PubMed Web of Science ®Google Scholar
• dos Santos Giuberti C, de Oliveira Reis EC, Ribeiro Rocha TG, et al. (2011). Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin. J Liposome Res 21:60–9
   PubMed Web of Science ®Google Scholar
• Drummond DC, Zignani M, Leroux J. (2000). Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 39:409–60
   PubMed Web of Science ®Google Scholar
• Ducat E, Deprez J, Gillet A, et al. (2011). Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int J Pharm 420:319–32
   PubMed Web of Science ®Google Scholar
• Düzgüneş N, Straubinger RM, Baldwin PA, et al. (1985). Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry 24:3091–8
   PubMed Web of Science ®Google Scholar
• Fattal E, Couvreur P, Dubernet C. (2004). Smart delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv Drug Deliv Rev 56:931–46
   PubMed Web of Science ®Google Scholar
• Ferreira SM, Domingos GP, Ferreira Ddos S, et al. (2012). Technetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitiveliposomes used to identify osteomyelitis. Bioorg Med Chem Lett 22:4605–8
   PubMed Web of Science ®Google Scholar
• Gerasimov OV, Boomer JA, Qualls MM, Thompson DH. (1999). Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv Drug Deliv Rev 38:317–38
   PubMed Web of Science ®Google Scholar
• Guo W, Gosselin MA, Lee RJ. (2002). Characterization of novel diolein-based LPDII vector for gene delivery. J Control Rel 83:121–32
   PubMed Web of Science ®Google Scholar
• Hong MS, Lim SJ, Oh YK, Kim CK. (2002). pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. J Pharm Pharmacol 54:51–8
   PubMed Web of Science ®Google Scholar
• Huang A, Tsao YS, Kennel SJ, Huang L. (1982). Characterization of antibody covalently coupled to liposomes. Biochim Biophys Acta 716:140–50
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang Z, Zhang Y, et al. (2012). Dual functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58
   PubMed Web of Science ®Google Scholar
• Junior AD, Mota LG, Nunan EA, et al. (2007). Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Sci 80:659–64
   PubMed Web of Science ®Google Scholar
• Kale AA, Torchilin VP. (2007). “Smart” drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J Liposome Res 17:197–203
   PubMed Web of Science ®Google Scholar
• Karanth H, Murthy RS. (2007). pH-sensitive liposomes–principle and application in cancer therapy. J Pharm Pharmacol 59:469–83
   PubMed Web of Science ®Google Scholar
• Khalil IA, Hayashi Y, Mizuno R, Harashima H. (2011). Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for livergene delivery. J Control Rel 156:374–80
   PubMed Web of Science ®Google Scholar
• Kim IY, Kang YS, Lee DS, et al. (2009). Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. J Control Rel 140:55–60
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee HJ, Lee IA, et al. (2008). Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes. Arch Pharm Res 31:539–46
   PubMed Web of Science ®Google Scholar
• Kono K, Zenitani K, Takagishi T. (1994). Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim Biophys Acta 1193:1–9
   PubMed Web of Science ®Google Scholar
• Koren E, Apte A, Jani A, Torchilin VP. (2012). Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Rel 160:264–73
   PubMed Web of Science ®Google Scholar
• Koynova R, Wang L, MacDonald RC. (2006). An intracellular lamellarenonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents. Proc Natl Acad Sci USA 103:14373–8
   PubMed Web of Science ®Google Scholar
• Lai MZ, Duzgunes N, Szoka FC. (1985). Effects of replacement of the hydroxyl group of cholesterol and tocopherol on the thermotropic behavior of phospholipid membranes. Biochemistry 24:1646–53
   PubMed Web of Science ®Google Scholar
• Lee KY, Chun E, Seong BL. (2002). Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH-sensitive liposomes encapsulated with Kb-restricted CTL epitope. Biochem Biophys Res Commun 292:682–8
   PubMed Web of Science ®Google Scholar
• Leite EA, Giuberti Cdos S, Wainstein AJ, et al. (2009). Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration. Life Sci 84:641–9
   PubMed Web of Science ®Google Scholar
• Leroux J, Roux E, Le Garrec D, et al. (2001). N-Isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J Control Rel 72:71–84
   PubMed Web of Science ®Google Scholar
• Leserman L, Machy P, Leonetti JP, et al. (1990). Targeted liposomes and intracellular delivery of macromolecules. Prog Clin Biol Res 343:95–102
   PubMedGoogle Scholar
• Li P, Liu D, Miao L, et al. (2012). A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomed 7:925–39
   PubMed Web of Science ®Google Scholar
• Litzinger DC, Huang L. (1992). Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim Biophys Acta 1113:201–27
   PubMed Web of Science ®Google Scholar
• Lutwyche P, Cordeiro C, Wiseman DJ, et al. (1998). Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Chemother 42:2511–20
   PubMed Web of Science ®Google Scholar
• Mo R, Sun Q, Li N, Zhang C. (2013). Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials 34:2773–86
   PubMed Web of Science ®Google Scholar
• Momekova D, Rangelov S, Lambov N. (2010). Long-circulating, pH-sensitive liposomes. Methods Mol Biol 605: 527–44
   PubMedGoogle Scholar
• Moore NM, Barbour TR, Sakiyama-Elbert SE. (2008). Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides. Mol Pharm 5:140–50
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kuramoto Y, Mukai H, et al. (2009). Enhanced gene transfection in macrophages by histidine-conjugated mannosylated cationic liposomes. Biol Pharm Bull 32:1628–31
   PubMed Web of Science ®Google Scholar
• Nayar R, Schroit AJ. (1985). Generation of pH-sensitive liposomes: use of large unilamellar vesicles containing N-succinyldioleoylphosphatidylethanolamine. Biochemistry 24:5967–71
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Agrawal GP, Vyas SP. (2011). Liposomal nanomedicine for breast cancer therapy. Nanomedicine (London) 6:1085–100
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Pal HC, et al. (2012). Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm 9:176–86
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Vyas SP. (2013). pH-sensitive liposome in drug delivery. In: Alvarez-Lorenzo C, Concheiro A, eds. Smart materials for drug delivery. Vol. 1. UK: Royal Society of Chemistry, 80–93
   Google Scholar
• Pedroso de Lima MC, Simões S, Pires P, et al. (2001). Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47:277–94
   PubMed Web of Science ®Google Scholar
• Pichon C, Midoux P. (2013). Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA. Methods Mol Biol 969:247–74
   PubMedGoogle Scholar
• Rodrigues PC, Beyer U, Schumacher P, et al. (1999). Acidsensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorg Med Chem 7:2517–24
   PubMed Web of Science ®Google Scholar
• Rosa M, Penacho N, Simöes S, et al. (2008). DNA pre-condensation with an amino acid-based cationic amphiphile. A viable approach for liposome-based gene delivery. Mol Membr Biol 25:23–34
   PubMed Web of Science ®Google Scholar
• Roux E, Francis M, Winnik FM, Leroux JC. (2002a). Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs. Int J Pharm 242:25–36
   PubMed Web of Science ®Google Scholar
• Roux E, Lafleur M, Lataste E, et al. (2003). On the characterization of pH-sensitive liposome/polymer complexes. Biomacromolecules 4:240–8
   PubMed Web of Science ®Google Scholar
• Roux E, Passirani C, Scheffold S, et al. (2004). Serum-stable and long-circulating, PEGylated, pHsensitive liposomes. J Control Rel 94:447–51
   PubMed Web of Science ®Google Scholar
• Roux E, Stomp R, Giasson S, et al. (2002b). Steric stabilization of liposomes by pH-responsive N-isopropylacrylamide copolymer. J Pharm Sci 91:1795–802
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Kojima C, Harada A, et al. (2008a). Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes. Bioconjug Chem 19:1588–95
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Kojima C, Harada A, et al. (2008b). The correlation between fusion capability and transfection activity in hybrid complexes of lipoplexes and pH-sensitive liposomes. Biomaterials 29:4029–36
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Kojima C, Harada A, Kono K. (2008c). Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH. Bioconjug Chem 19:1040–8
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al. (2006). “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943–9
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cevc G, Marsh D. (1983). Calorimetric studies of the gel-fluid (L beta–L alpha) and lamellar-inverted hexagonal (L alpha-HII) phase transitions in dialkyl- and dia- cylophosphatidylethanolamines. Biochemistry 22:1280–9
   PubMed Web of Science ®Google Scholar
• Shi G, Guo W, Stephenson SM, Lee RJ. (2002). Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Rel 80:309–19
   PubMed Web of Science ®Google Scholar
• Shigeta K, Kawakami S, Higuchi Y, et al. (2007). Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. J Control Rel 118:262–70
   PubMed Web of Science ®Google Scholar
• Simard P, Leroux JC. (2009). pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells. Int J Pharm 381:86–96
   PubMed Web of Science ®Google Scholar
• Simard P, Leroux JC. (2010). In vivo evaluation of pH-sensitive polymer-based immunoliposomes targeting the CD33 antigen. Mol Pharm 7:1098–107
   PubMedGoogle Scholar
• Simoes S, Moreira JN, Fonseca C, et al. (2004). On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Del Rev 56:947–65
   PubMed Web of Science ®Google Scholar
• Simoes S, Slepushkin V, Duzgunes N, et al. (2001). On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes. Biochim Biophys Acta 1515:23–37
   PubMed Web of Science ®Google Scholar
• Slepushkin VA, Simoes S, Dazin P, et al. (1997). Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem 272:2382–8
   PubMed Web of Science ®Google Scholar
• Soares DC, Cardoso VN, de Barros AL, et al. (2012). Antitumoral activity and toxicity of PEG-coated and PEG-folate-coated pH-sensitive liposomes containing 159Gd-DTPA-BMA in Ehrlich tumor bearing mice. Eur J Pharm Sci 45:58–64
   PubMed Web of Science ®Google Scholar
• Soenen SJ, Brisson AR, De Cuyper M. (2009). Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 30:3691–701
   PubMed Web of Science ®Google Scholar
• Subbarao NK, Parente RA, Szoka FC, et al. (1987). pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 26:2964–72
   PubMed Web of Science ®Google Scholar
• Sudimack JJ, Guo W, Tjarks W, Lee RJ. (2002). A novel pH sensitive liposome formulation containing oleyl alcohol. Biochim Biophys Acta 1564:31–7
   PubMed Web of Science ®Google Scholar
• Tachibana R, Harashima H, Shono M, et al. (1998). Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. Biochem Biophys Res Commun 251:538–44
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Zhou F, Huang L. (1993). pH-sensitive liposomes. J Liposome Res 3:201–55
   Google Scholar
• Torchilin VP. (1985). Liposomes as targetable drug carriers. CRC Crit Rev Ther Drug Carrier Syst 1:65–115
   Google Scholar
• Torres E, Mainini F, Napolitano R, et al. (2011). Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Rel 154:196–202
   PubMed Web of Science ®Google Scholar
• Venugopalan P, Jain S, Sankar S, et al. (2002). pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie 57:659–71
   PubMed Web of Science ®Google Scholar
• Wang CY, Huang L. (1986). pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA 84:7851–5
   Web of Science ®Google Scholar
• Wang CY, Huang L. (1987). pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA 84:7851–5
   PubMed Web of Science ®Google Scholar
• Watabe S, Xin KQ, Ihata A, et al. (2001). Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19:4434–44
   PubMed Web of Science ®Google Scholar
• Watarai S, Iwase T, Tajima T, et al. (2013). Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier. Sci World J 2013:1–7
   Google Scholar
• Webb MS, Wheeler JJ, Bally MB, Mayer LD. (1995). The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery. Biochim Biophys Acta 1238:147–55
   PubMed Web of Science ®Google Scholar
• Woodle MC, Matthay KK, Newman MS, et al. (1992). Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta 1105:193–200
   PubMed Web of Science ®Google Scholar
• Xia G, An Z, Wang Y, et al. (2013). Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome. Chem Pharm Bull (Tokyo) 61:390–8
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Kreutz W, Horwitz B, Shinitzky M. (1980a). Induced drug release from lipid vesicles in serum by pH-change. Biophys Struct Mech 6:233–4
   PubMedGoogle Scholar
• Yatvin MB, Kreutz W, Horwitz BA, Shinitzky M. (1980b). pH-sensitive liposomes: possible clinical implications. Science 210:1253–5
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Okada N, Oda A, et al. (2008). Development of amphiphilic g-PGA-nanoparticulate cytosolic protein delivery carrier. Biochem Biophys Res Commun 366:408–13
   PubMed Web of Science ®Google Scholar
• Yu B, Tai HC, Xue W, et al. (2010). Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol 27:286–98
   PubMed Web of Science ®Google Scholar
• Yuba E, Kojima C, Harada A, et al. (2010). pH-sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity. Biomaterials 31:943–51
   PubMed Web of Science ®Google Scholar
• Yuba E, Harada A, Sakanishi Y, et al. (2013). A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials 34: 3042–52
   PubMed Web of Science ®Google Scholar
• Zhou F, Huang L. (1995). Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway. J Drug Target 3:91–109
   PubMed Web of Science ®Google Scholar
• Zignani M, Drummond DC, Meyer O. (2000). In vitro characterization of a novel polymeric-based pH-sensitive liposome system. Biochim Biophys Acta 1463:383–94
   PubMed Web of Science ®Google Scholar